Javle et al. [21] investigated TGFβ1 plasma levels in patients with pancreatic ductal adenocarcinoma and showed that an increase in its levels was accompanied by a short survival time. The gene discussed is TGFB1; the disease is pancreatic ductal adenocarcinoma.